MAR 15, 2022 4:30 PM PDT

Moderna begins clinical trial for its second HIV vaccine

WRITTEN BY: J. Bryce Ortiz

On Monday, March 14, the biotech company Moderna announced that the first participant had been dosed with a new vaccine that aims to protect against HIV. The participant is enrolled in an open-label, multicenter, Phase 1 clinical trial for the vaccine that is designed to test the safety and efficacy of the vaccine. 

Moderna, who is well known for its COVID-19 vaccine, is built upon an mRNA technology platform. The company currently has over 40 separate vaccines in its pipeline, of which close to 10 are in clinical trials. The company’s vaccines treat a wide range of diseases including various types of cancer. Additionally, the company is currently in clinical trials with two separate HIV vaccines.

The HIV vaccine that begun testing this week isd  unique in that it targets HIV envelope trimers via mRNA. HIV, like other viruses, is an enveloped virus but the variability of the HIV envelope and the way it interacts with hosts cells makes HIV particularly difficult to treat. However, research from the company, which was published last year in the journal nature medicine, showed that the mRNA vaccine that targeted HIV envelope proteins led to a broad neutralization of the virus, and a significant reduced risk of infection of HIV in experimental animals exposed to the virus. With this information, the company moved to clinical trials in humans.

HIV (Human Immunodeficiency Virus) is the virus that causes acquired immunodeficiency syndrome (AIDS) in humans. Since the beginning of the AIDS epidemic, the disease has killed over 36 million people. And the disease continues to spread, with an estimated 1.5 million people being infected with HIV in the year 2020 alone. Once an individual is infected, the virus can attack the body’s immune system and lead to AIDS. There is currently no effective cure for HIV, but there are many treatments which help to reduce or even eliminate the risk of transmission in affected individuals. However, many experts believe that an effective vaccine against HIV will be critical for ridding the world of the virus. 

Dr. Stephen Hoge, President of Moderna, said that the development of an HIV vaccine has been difficult to achieve, but his company believes that mRNA technology offers an opportunity for a new approache to this challenge. He added, “with the launch of our second HIV vaccine trial, we are advancing our strategy to utilize multiple mRNA encoded native-like HIV trimers and leverage the power of our mRNA platform to accelerate the discovery of a protective HIV vaccine.” The end results from the ongoing clinical of this HIV vaccine are expected early next year. 

 

Sources: ModernaClinicalTrials.govModernaScientific Reportsnature medicineWorld Health OrganizationCenters for Disease ControlHIV.gov;

About the Author
PhD in Neuroscience
Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
AUG 02, 2022
Cell & Molecular Biology
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
AUG 02, 2022
A New, Innovative Process for Clarifying and Sterile Filtering Cells for Protein Purification Workflows
Introduction Centrifugation and filtration have been widely accepted as techniques required for clarifying complex cell ...
JUN 10, 2022
Drug Discovery & Development
The consequences of inappropriate antibiotic prescriptions in children
JUN 10, 2022
The consequences of inappropriate antibiotic prescriptions in children
The discovery of antibiotics in the early 1900’s was one of the most important discoveries in medical history. The ...
JUL 08, 2022
Cannabis Sciences
$2 Million in NIH Awards go to Study Adolescent Cannabis Use
JUL 08, 2022
$2 Million in NIH Awards go to Study Adolescent Cannabis Use
The NIH's National Institute on Drug Abuse awarded more than $2 million to Indiana University’s Gill Center fo ...
JUL 15, 2022
Cannabis Sciences
Cannabis Legalization's Impact on Foster Care Placements
JUL 15, 2022
Cannabis Legalization's Impact on Foster Care Placements
A study published in the journal Economic Inquiry analyzed the potential impacts of federal cannabis legalization on fos ...
JUL 23, 2022
Drug Discovery & Development
Anti-inflammatory Compound Shows Promise in Treating Severe COVID-19
JUL 23, 2022
Anti-inflammatory Compound Shows Promise in Treating Severe COVID-19
An anti-inflammatory compound has shown promise in treating systemic inflammation and brain injury in patients with seve ...
JUL 23, 2022
Drug Discovery & Development
Antibiotics Affect Gut Microbiome of Male and Female Rats Differently
JUL 23, 2022
Antibiotics Affect Gut Microbiome of Male and Female Rats Differently
Antibiotics induce sex-specific effects on the gut microbiome of male and female rats. The corresponding study was publi ...
Loading Comments...